NextGen Oncology • MUDr Martin Lužbeták, MSc

07/10/2024

We are pleased to share that MUDr. Martin Lužbeták participated as a speaker at the XI. DGHT Congress in Düsseldorf, where he presented an enlightening talk titled: "Hyperthermie Behandlungen eingebettet im multitherapeutischen Kontext."

His talk highlighted the innovative approaches in hyperthermia treatments and their integration into a comprehensive multi-therapeutic strategy. We are incredibly proud to contribute to the ongoing advancements in cancer therapies through such cutting-edge research and treatment methodologies.

A huge thank you to Dr. med. Hüseyin Şahinbaş and the Deutsche Gesellschaft für Hyperthermie e.V. for organizing this inspiring event and for their continued efforts in promoting hyperthermia therapy in cancer treatment.

27/07/2024

great talk!

Thanks to Brad Powers and Mark Taylor!

October 4, 2023Discussion forum: https://community.cancerpatientlab.org/c/pancreatic-cancer/A complete transcript: https://docs.google.com/document/d/1MDniJ7...

06/06/2024

Wir möchten Sie gerne auf folgende Veranstaltung hinweisen, an der MUDr. Martin Lužbeták als Referent und Aussteller teilnimmt.
Onkologie-Tagung
08.06.2024 Holiday Inn München-Unterhaching
Vortrag
Samstag, 08. Juni • 15.30 - 16.15 Uhr
”Die Chemie der Pflanzenstoffe - Was wirkt wann"
Genexpressionsanalysen als Entscheidungshilfe in der Naturmedizin

Wir freuen uns, Sie in München begrüßen zu dürfen.

04/06/2024

MUDr. Martin Luzbetak im Gespräch mit Vlasta Prohaska vom Verlag Planetopijin im Rahmen einer Konferenz in Zagreb.

Einleitung: Kroatisch, Interview: Englisch

In diesem interessanten Gespräch mit dem Planetopia-Podcast spricht MUDr. Martin Luzbetak über seinen integrativen Ansatz in der Krebsbehandlung. Dabei verrät er, warum ihm komplementäre Therapien, Prävention und die Erhaltung der Lebensqualität seiner Patienten so am Herzen liegen und was ihn antreibt, sich täglich für sie einzusetzen.

Integrativni pristup u liječenju raka tema je ove epizode Planetopijinog podcasta u kojoj smo razgovarali s dr. Martin Luzbetakom koji već 10 godina pomaže l...

10/04/2024

MUDr Martin Lužbeták, MSc nimmt als Keynote-Speaker an der "Integrative Medicine in Focus: From Complementary Therapy to Complete Health" Konferenz in Zagreb teil.

30/01/2024

Fifty-seven-year-old Caucasian male presented with a 6-month history of epiphora. Multimodal examination revealed a unilateral lacrimal sac SCC T4aN0M0. The patient underwent primary surgery with subsequent chemoradiotherapy. The patient was alive 18 months after the end of the treatment, with no signs of local or distant relapse. Complex molecular profiling revealed the FGFR p.G388R variant, HER2 amplification, and progression phenotype.

Abstract. Introduction: Lacrimal sac squamous cell carcinoma (SCC) is a rare tumor. Only 241 cases of lacrimal sac SCC have been reported in the literature. However, the detailed molecular profile of this tumor is unknown. Case Presentation: Fifty-seven-year-old Caucasian male presented with a 6-mon...

04/11/2023

Local cancer ablation meets hyperthermia meets immuno oncology.
Hüseyin Şahinbaş, MD, Prof. Attila Kovács, MD, and Martin Lužbeták, MD, during the keynote speech "Minimally invasive procedures in oncology" at the Medical Week in Baden-Baden.